Arkadios Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$903K Buy
13,405
+455
+4% +$30.3K 0.01% 848
2026
Q1
$813K Buy
12,950
+9,730
+302% +$678K 0.01% 891
2025
Q4
$214K Sell
3,220
-1,628
-34% -$105K ﹤0.01% 1420
2025
Q3
$326K Buy
4,848
+2,363
+95% +$187K 0.01% 1129
2025
Q2
$217K Buy
+2,485
New +$195K 0.01% 1182
2021
Q4
Sell
-260
Closed -$35K 883
2021
Q3
$35K Hold
260
0.01% 1002
2021
Q2
$27K Buy
260
+96
+59% +$9.22K ﹤0.01% 1157
2021
Q1
$14K Buy
164
+4
+3% +$375 ﹤0.01% 1079
2020
Q4
$14K Sell
160
-80
-33% -$7.14K ﹤0.01% 861
2020
Q3
$24.3K Sell
240
-40
-14% -$4.18K 0.01% 561
2020
Q2
$28.7K Hold
280
0.02% 478
2020
Q1
$18.8K Buy
280
+92
+49% +$5.72K 0.01% 499
2019
Q4
$11.9K Buy
+188
New +$8.92K 0.01% 552

Other funds holding DXCM

Arkadios Wealth Advisors's DXCM Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its DexCom (DXCM) stake by 3.5% in Q2 2026, buying an estimated $30.3K and bringing the position to 13,405 shares worth $903K. The position accounts for 0.01% of the portfolio, ranked #848.

Arkadios Wealth Advisors first reported a position in DXCM in Q4 2019 and has held it in 13 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Arkadios Wealth Advisors held 13,405 shares of DexCom worth $903K as of Q2 2026.
  • Arkadios Wealth Advisors bought 455 DexCom shares in Q2 2026, an estimated $30.3K.
  • DexCom made up 0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #848 holding.
  • Arkadios Wealth Advisors first reported a position in DexCom in Q4 2019 and has held it in 13 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.